AMGEN AND ARRAKIS THERAPEUTICS ANNOUNCE MULTI-TARGET COLLABORATION TO IDENTIFY NOVEL RNA DEGRADER SMALL MOLECULE THERAPEUTICS

THOUSAND OAKS, Calif. and WALTHAM, Mass.: THOUSAND OAKS, Calif. and WALTHAM, Mass., Jan. 11, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Arrakis Therapeutics today announced a research collaboration focused on the discovery and development of RNA degrader therapeutics against a range of difficult-to-drug targets in multiple therapeutic areas. This new class...

Click to view original post